Nanoparticle-based gene editing could expand treatment options for cystic fibrosis
Medical Xpress
February 17, 2026
UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells, restoring key biological function in a laboratory model of cystic fibrosis and establishing a potential new path toward mutation-agnostic gene therapy for inherited lung diseases.
Verticals
healthmedical
Originally published on Medical Xpress on 2/17/2026